Fernando U. Garcia,MD


Pathologist, CTCA Philadelphia

Fernando U. Garcia - Pathologist

I am proud to serve our patients and their families.

CTCA Philadelphia
Medical school:
Universidad Peruana Cayetano Heredia Medical School, Lima, Peru
Pathology - University of Kansas, Lawrence
Surgical Pathology & Infectious Diseases - Vanderbilt University, Nashville, TN

Anatomic Pathology & Cytopathology - American Board of Pathology


Dr. Fernando Garcia graduated from Universidad Peruana Cayetano Heredia Medical School in Lima, Peru. He completed a residency in pathology at the University of Kansas, followed by a fellowship in surgical pathology and infectious diseases at Vanderbilt University in Tennessee.

His professional background includes extensive experience at Kansas University at Kansas City, where he served as Director of the Tissue Culture Core Facility, Medical Director of the Cytopathology Laboratory, Director of Dermatopathology and as Assistant Professor of the Pathology Department.

Dr. Garcia also spent 10 years at Drexel University College of Medicine, where he was a professor, Medical Director of Immunopathology, Medical Director of the Image Analysis Laboratory and Medical Director of Tissue Procurement Core. Most recently, Dr. Garcia was the Regional Director of Anatomic Pathology and Medical Director and Service Chief of Hahnemann University Hospital.

Dr. Garcia has served on numerous institutional and departmental committees and is a frequent guest speaker. He has published over 40 peer-reviewed articles in multiple areas, having special interest in breast and prostate pathology. Additionally, he belongs to several professional associations, including the American Society of Cytopathology, American Association for Cancer Research and the Association of Directors of Anatomic and Surgical Pathology.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.